Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

NeXstar initiates third phase II MiKasome trial

July 21, 1998

Sankyo presents new antifungal agents for Candida infections

July 20, 1998

Antibacterial agent of microbial origin discovered by Sankyo

July 20, 1998

Pola discloses new antifungal agents

July 17, 1998

Locally applied fusafungine for rhinitis and sinusitis

July 17, 1998

Cephalosporins described by Roche for Gram-positive infections

July 16, 1998

Novel antimicrobial lipid compounds for preventing STDs

July 16, 1998

New semisynthetic macrolide antibiotics designed by Pliva

July 15, 1998

NeXstar initiates second part of MiKasome phase II trial and reports preliminary findings

July 15, 1998

Potent, broad-spectrum cephalosporin antibiotics in the pipeline at Roche

July 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...